Pulido Vina, Lee Shin Yin, Ko Naomi Yu
Department of Medicine, Boston Medical Center, Boston, Mass., USA.
Section of Hematology/Oncology, Department of Medicine, Boston Medical Center, Boston, Mass., USA.
Case Rep Oncol. 2016 Jun 27;9(2):351-357. doi: 10.1159/000447351. eCollection 2016 May-Aug.
In the era of precision medicine and targeted therapy, diagnostic inaccuracy can have tremendous ramifications. We present the case of a 61-year-old man initially diagnosed with small cell lung cancer by pathology. Prior to initiating chemotherapy, multidisciplinary discussions led to an amendment of the diagnosis to medullary thyroid cancer.
在精准医学和靶向治疗时代,诊断不准确可能会产生巨大影响。我们报告一例61岁男性病例,该患者最初经病理诊断为小细胞肺癌。在开始化疗之前,多学科讨论后将诊断修正为甲状腺髓样癌。